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ABSTRACT 
 
Background. The ideal duration of intravascular administration set use is unknown. Studies 
have compared the infective implications of one to seven days of use. The Centers for Disease 
Control recommend at least three days usage. No previous study has evaluated the accuracy 
of volume delivery or integrity of administration sets after prolonged use. 
 
Aim. To evaluate the accuracy and condition of intravascular administration sets used 
continuously for 7 days. 
 
Design. Prospective, randomised, experimental study in the laboratory setting. 
 
Methods. Four administration sets were randomly assigned to deliver 2 mL/h (IMED 
syringe set 2280-0000), 20, 50 or 100 mL/h (IMED infusion sets 2210-0500) of crystalloid 
solution continuously for 7 days through an IMED Gemini four channel infusion pump 
(PC4).  At study commencement and daily for 7 days, a 4 hour volume measurement and an 
inspection for leaks/erosion of administration sets occurred for each administration set (total 
measurements = 32). 
 
Results. Mean volume outputs over four hours were 7.84mL (2mL/h), 80.66 mL (20mL/h), 
205.35 (50 mL/h) and 406.37 (100 mL/h). These differed significantly from the programmed 
volumes (p = 0.00 – 0.01). Usage duration did not influence performance (F = 0.866, p = 
0.55). Accuracy of volume delivery differed significantly with pump speed (F = 106.933, p < 
0.001) exhibiting increased volume to 50 mL/h then a reduction at 100 mL/h. Differences 
were within manufacturer specifications (+/- 5%) and were clinically acceptable. All 
administration sets remained in appropriate condition displaying no leakage or erosion. 
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Conclusion. There were small inaccuracies found between programmed and delivered 
volumes however there was no deterioration in performance over time. This suggests that 
inaccuracies were due to normal pump performance rather than the administration sets. 
Administration sets retain acceptable accuracy and condition after 7 days continuous use. 
Further research should assess the infective and other impacts of prolonged usage. 
 
(Word count = 300) 
 
Keywords: Infusions, Intravascular; Infusions, Parenteral; Infusion Pumps; Randomised 
Controlled Trial; Research. 
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BACKGROUND 
 
Introduction 
 
Intravascular administration sets are used for the administration of fluid, nutrition and 
medication, and also for the maintenance of intravascular pressure monitors (Raad & 
Darouiche et al. 1997). The administration set is minimally a length of tubing (often called a 
“giving set”) connecting to the fluid reservoir (commonly a bag or syringe) at one end, and to 
the intravascular catheter at the other. Additionally, they may be enhanced by the 
incorporation of burettes or extension tubing, which should also be considered part of the 
administration set. Duration of administration set usage is determined by three factors. The 
first factor, commonly focussed on in the literature, is the potential for administration sets to 
provide a portal for infection. The second factor, also discussed in the literature, is the 
significant financial costs of administration sets and the nursing time required to configure 
them. The third factor seems to be the most basic, the actual physical capability of 
administration sets to continue performing acceptably over a prolonged period of time. The 
relationship between physical performance and duration of administration set use has not 
been addressed previously in the literature. 
 
Historical Developments 
 
Prior to 1970, administration sets were changed only when intravenous therapy was ceased or 
if the administration sets malfunctioned (Maki et al. 1976). In 1970 and 1971, an epidemic of 
catheter-related infection ensued in the United States secondary to manufacturer contaminated 
intravenous fluid. In 1971, in response, the Centers for Disease Control (CDC) recommended 
that 24 hour routine administration set changes be implemented. This practice became 
internationally accepted in developed countries and was not questioned for some years until 
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researchers began to publish studies advocating the prolongation of usage to 48 hours which 
allowed costs savings with no impact on infection (Band & Maki, 1979, Buxton et al.1979, 
Gorbea et al. 1984). In 1982, the CDC revised its guidelines to support the 48-hour 
administration set usage in most circumstances (CDC Working Group 1982). Researchers 
continued to examine the issue, evaluating 72, 96 and 120-hour usage (Josephson et al. 1985, 
Sitges-Serra et al. 1985, Jacobsen et al. 1986, Maki et al. 1987, Snydman et al. 1987, 
Robathan et al. 1995, Matlow et al. 1999). The CDC last revised its recommendations in 1996 
to advocate the replacement of administration sets ‘72 hours or more after initiation of use’ 
(Pearson et al. 1996 p.269). The actual duration of usage currently practiced by clinicians is 
unknown, with manufacturers advising replacement as per ‘CDC guidelines or hospital 
policy’ (ALARIS Medical Systems 1999 p.1). There have been two studies published 
giving some support to 168 hour administration set use (Chen et al. 2000, Raad & Hanna et 
al. 2001) and it is suspected some hospitals have implemented 168 hour or even longer 
intervals between changing administration sets, motivated by the reduction in material costs 
that this can achieve. Notably, all published works have focussed on infection control and 
financial endpoints, with none commenting on the physical condition or capability of 
administration sets after prolonged use. 
 
Duration of Intravascular Administration Set Use and Infection Risk 
 
Intravascular catheters break the skin, the body’s natural defence barrier, putting the patient at 
risk of hospital acquired infection (Band & Maki 1979). This may lead to overwhelming costs 
not only for the patient, but also for the health system in terms of increased length of stay and 
treatment costs (Darouiche & Raad 1998). Pathogens may enter the patient at either the 
catheter skin site, or through any of the connections of the administration set. Intravenous 
fluid may harbour microorganisms, and upon connection to the administration set, these 
microorganisms may travel through the set and into the patient’s vasculature. Alternately, the 
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administration set may be contaminated from the hands of clinicians or from the physical 
environment when the various interlocking sites of the system are connected or disconnected. 
Clinicians manipulate administration sets on multiple occasions; to initially set up the system, 
to accommodate changing treatment needs (such as adding a burette or extension tubing), to 
replace fluid bags and/or syringes. Many strategies are used by clinicians to minimise the risk 
of infection, one of these being the routine replacement of administration sets more frequently 
than the catheter itself is resited. 
 
Duration of Intravascular Administration Set Use and Financial Costs 
 
Due to the high volume of administration sets used in acute care settings, variation in duration 
of use has significant cost implications. The routine replacement of an administration set 
requires multiple possible variations of syringes, giving sets, burettes, extension and/or 
transducer tubing. Additionally required are new intravenous fluids (with or without 
medication additives), the dedicated time of one or more skilled nurses, large amounts of 
sterile products and the associated infection control drapes, gowns, gloves, disinfectants and 
so on. A single patient’s administration set change may be up to $A300 in material costs 
alone for a complex intensive care patient. For an 18-bed unit such as the authors’, decreasing 
routine administration set replacements from the current twice per week to a once per week 
policy would lead to savings of up to $A115,000 per year. It is not surprising, therefore, that 
hospitals have been eager to prolong administration set usage. 
 
Duration of Intravascular Administration Set Use and Administration Set 
Performance 
 
It is of utmost importance that administration sets are used in appropriate condition. An 
inaccurate administration set will not deliver prescribed treatment, perhaps leading to 
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subtherapeutic or over-dosage. Leakage of fluid from administration sets may pose an 
electrical or slippage hazard. Cytotoxic or biological fluids additionally may put the patient, 
visitors or staff at risk. It is likely that clinicians and researchers will continue to evaluate an 
increasingly prolonged duration of administration set usage. Although one could assume that 
administration set performance remained acceptable in the previously published infection-
focussed studies, it is not necessarily safe to do so. The research projects were designed to 
detect changes in infection parameters (Band & Maki 1979, Buxton et al. 1979, Gorbea et al. 
1984, Josephson et al. 1985, Sitges-Serra et al. 1985, Jacobsen et al. 1986, Maki et al. 1987, 
Snydman et al. 1987, Robathan et al. 1995, Matlow et al. 1999, Chen et al.2000), Raad & 
Hanna et al. 2001) and it is possible that any trends in physical performance may have been 
overlooked. Presumably manufacturers have tested their equipment, although to what time 
frame is unknown, as this data has not been published. Administration sets are a disposable 
item subjected to physical pressures from the mechanical pump and staff/patient actions. 
Intuitively, the physical wear and tear sustained during use must eventually reduce 
performance, although the time frame for this to occur is unknown. Infection control is 
obviously a major concern when determining the appropriate length of administration set 
usage. However, as studies continue to be published without any report of the physical 
performance of administration sets, it becomes more concerning whether these administration 
sets suffer loss of accuracy or physical integrity over time. 
 
AIMS 
 
The aims of this study were: 
1. To test the accuracy of volume delivery of administration sets over 7 days of 
continuous use. 
2. To test the physical condition of administration sets over 7 days of continuous use. 
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DESIGN 
 
This study utilised a prospective, randomised, experimental design with repeated measures. 
 
HYPOTHESES 
 
There is no significant difference between the programmed and delivered volumes of 
administration sets over 7-days of continuous use. 
 
There is no significant difference in the physical condition of administration sets used 
continuously over 1, 2, 3, 4, 5, 6 and 7 days. 
 
METHOD 
 
Setting 
 
The study was undertaken in 1998 in the laboratory of the Department of Intensive Care, 
Royal Brisbane Hospital. The Royal Brisbane Hospital is an 800 bed, tertiary level, university 
affiliated hospital. 
 
Sample and Equipment 
 
Daily repeated measures were undertaken on four administration sets, which were the unit of 
measurement for the study (N=4). Three IMED infusion (2210-0500) administration sets and 
one IMED syringe (2280-0000) administration set were studied in the laboratory setting for 
7 days of continuous use. Administration sets were infused through the commonly used 
IMED Gemini four channel infusion pumps (PC4, ALARIS Medical Systems, San 
 9 
Diego, CA, USA). The same infusion pump channel was used for each administration set for 
the duration of the study. 
 
Procedures and Data Collection 
 
Administration sets were set up by a registered nurse as per clinical practice and 
manufacturer’s instructions to deliver 2, 20, 50 or 100 mL/h of crystalloid solution. The 
syringe administration set was used at 2 mL/h. Infusion administrations sets were used for the 
other three pump settings. The pump speeds were selected to reflect clinically relevant rates 
and were randomly assigned to each administration set. The administration sets were run 
continuously through the pump at the assigned rate for 7 days. Immediately on commencing 
the experiment and at 24-hour intervals (each day) thereafter for 7-days, all eluent from the 
pump was collected for a precisely measured 4-hour period by a laboratory scientist (S.W.). 
The total period of the experiment was therefore 172 hours; 168 hours for the 7 day 
experiment plus the final four hour measuring period after day 7 had elapsed.  
 
Eluent was collected in scientifically exact glass measuring cylinders. During collection, the 
measuring cylinders were covered with Parafilm laboratory film to seal against any 
evaporation (American National Can, Greenwich, CT USA). The volume and tolerance of the 
cylinders, and the accuracy with which they could be read, for each pump speed is shown in 
Table 1. 
 
Daily inspection of administration sets was undertaken by one of the investigators (C.R.) to 
assess for any deterioration in physical condition over time. Administration sets were 
examined visually and manually in a brightly lit room to assess for fluid leakage and for any 
signs of physical erosion. 
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(Insert Table 1) 
 
Statistical Analysis 
 
Descriptive statistics were calculated for all variables. Paired t-tests were performed to test for 
difference in programmed and delivered volumes for each of the administration sets. The 
administration set was the unit of measurement. Output volumes from all four administration 
sets were standardised to the 2 mL/h set to allow comparison between performances at 
differing speeds of volume delivery. A general linear model (ANOVA) +/- a Scheffe post hoc 
test to isolate difference was fitted to the standardised values to determine the effect of day of 
measurement and effect of volume delivery rate on the accuracy of volume delivery. As there 
was a null incidence of physical deterioration amongst the administration sets, further analysis 
was inappropriate for this variable. 
 
Institutional Approval 
 
Institutional Ethics Committee approval was not required as this was an in vitro study with no 
impact on patient care or confidentiality. The nursing and medical directors reviewed the 
research proposal prior to implementation and their consent for use of resources was obtained. 
 
RESULTS 
 
Accuracy of Volume Delivery 
 
The mean output for the 2, 20, 50, and 100 mL/h administration sets over 4 hours was 7.84, 
80.66, 205.35 and 406.37 mL respectively. This is in contrast to the respective programmed 
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outputs of 8 mL, 80 mL, 200 mL and 400 mL. The minimum, maximum and mean 4-hour 
volume outputs appear in Table 2. 
 
(Insert Table 2) 
 
To assess the accuracy of infusate volume delivered, t-tests were performed for each of the 4 
administration sets to test for any difference between the mean 4 hour programmed and 
delivered volumes over the 7 day test period. For each of the 4 administration set speeds (2, 
20, 50 and 100 mL/h), the test value was set at the mean programmed volume expected to 
have been delivered over the 4-hour test period for each respective administration set (8 mL, 
80 mL, 200 mL and 400 mL). All four of the administration sets were found to output a 
significantly different mean volume when compared with the mean programmed volume at a 
5% level of significance (p = 0.000 - 0.014). The results of this analysis appear in Table 3. 
 
(Insert Table 3) 
 
ANOVA was fitted to the standardised values to determine the effect of day of measurement 
on accuracy. Individual days of measurement did not significantly effect accuracy (F = 0.866, 
p = 0.55) for any of the administration sets. That is, once the administration set was set to a 
particular setting it stayed the same, on average, over time. If the administration set under-
infused, it tended to under-infuse each day and vice-versa for over-infusers. Although there 
was variation each day, on average over time there was no change. Although the 
administration sets were not accurate, they were precise over time in their inaccuracy. Figure 
1 displays the delivered volumes of the 4 administration set speeds standardised to 2 mL/h 
against each day of measurement. The nominal programmed volume output over the four 
hours was 8.0 mL for all four administration sets once standardised to 2 mL/h. 
 
(Insert Figure 1) 
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ANOVA was also fitted to the standardised values to determine the effect of volume delivery 
rate on accuracy. Figure 2 displays the change in mean standardised delivered volumes 
against each programmed administration set rate (the nominal programmed volume output 
over the four hours was 8.0 mL for all four administration sets once standardised to 2 mL/h). 
The mean standardised values for administration set rates of 2 mL/h (7.84 mL), 20 mL/h 
(8.04 mL), 50 mL/h (8.21 mL) and 100 mL/h (8.12 mL) were significantly different from 
each other (F = 106.933, p < 0.001). A Scheffe post hoc test was applied to find out where the 
difference in performance occurred, and found that all 4 administration sets were significantly 
different from each other (when standardised) at a 5% level of significance. There was a trend 
to increasing output with administration set rates up to 50 mL/h with a reduction back at 100 
mL/h. 
 
(Insert Figure 2) 
 
Administration Set Condition 
 
There was no fluid leakage detected from any of the administration sets on any of the daily 
assessments. Similarly there was no evidence of erosion in the physical condition of the 
administration sets on any of the daily assessments. All administration sets remained in 
appropriate condition and, therefore, the planned statistical analysis was not undertaken for 
this variable. 
 
DISCUSSION 
 
This study has found administration set performance and condition to be indistinguishable 
after 7 days of continuous use, from that at commencement of use. Infection control issues 
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aside, this study provides support for prolonged use of intravascular administration sets of up 
to 7 days continuous use. Although the study found statistical differences between 
programmed and delivered volumes, discrepancies were not related to the duration of 
administration set usage. That is, there was no detectable deterioration over time in 
performance. The administration sets were not accurate, but they were no more or less 
accurate after 7-days of continuous use. The inaccuracies found did not seem to be a 
reflection on the performance of administration sets, but rather the ‘normal’ variation inherent 
in infusion pump performance. The manufacturer’s specification for the infusion pump 
accuracy is +/- 5.0%. The difference detected in this study between programmed and 
delivered volumes ranged from -2.0 to + 2.7% and thus was well within the +/- 5.0% 
parameter. From a clinical perspective, the errors in volume delivery were small and should 
be interpreted as clinically acceptable error and of no risk to patients.  
 
This study is the first to specifically address the appropriateness of using intravascular 
administration sets for extended periods of time from the perspectives of accuracy of volume 
delivery and administration set condition. The findings are significant because they 
complement results from previous works, which promote extended administration set usage 
as beneficial from financial and infection control perspectives. The results give support to 
clinicians who have chosen to implement findings from the few studies that have promoted 
>72 hour use. 
 
This study should not be used as a basis for implementing 7 day administration set use in the 
clinical setting, as the study was not designed to evaluate the effect of 7 day use on catheter 
infection. There are only two in vivo studies to date evaluating the appropriateness of this 
time frame (Chen et al. 2000, Raad & Hanna et al. 2001). The study by Chen et al. has, to 
date, only been published in abstract form and although it recommends extended usage, there 
are concerns with generalisability because of its high reported catheter infection rate of 23%, 
as opposed to the more universally accepted rates of 3-7% quoted in the literature (Maki 
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1994). Raad & Hanna et al. have fully published their findings, and recommend extended 
usage in patients with a low risk of infection, however the study was small with only 26 
patients receiving 7 day administration set changes. 
 
Infusion rates chosen in the study were selected for their clinical relevance as rates commonly 
used in the adult patient population. It is possible that administration sets may perform 
differently at other rate settings, for example the miniscule volumes required in the treatment 
of neonatal patients (such as 0.1 mL/h). 
 
It is possible that the same study with a larger sample size would have provided a different 
result. However although relatively few (four) administration sets were studied, the repeated 
measures design of four sets over 172 hours meant that the sample effectively consisted of 32 
data points. Additionally the effect size of the experiment, with the finding of statistical 
significance in one variable (volume delivered) and the nil incidence of the other variable (set 
condition) suggests that a larger sample would not necessarily have yielded different data. 
 
Each administration set was studied using the same infusion pump for the course of the study. 
This was done to control for any effect of the pumps on accuracy however it does leave open 
the question of whether inaccuracies detected were because of the inherent error of that 
particular pump or of all pumps at that setting. It was assumed for the purposes of this study 
that the regular servicing and testing regime endured by the infusion pumps rendered them 
identical to each other in performance. 
 
Unfortunately one of the data points (the day 2) for volume output measurement of the 50 
mL/h pump was missing due to the researcher error of not replacing the fluid bag before it ran 
through. This was treated on statistical analysis as missing data and it is doubtful that this 
would have significantly affected the results. The pump in question was continued and 
measured for an additional day after the conclusion of the study and whilst these results are 
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not reported, the reader may be interested to know that the results were comparable to those 
reported and included in analysis. 
 
In the clinical setting, intravenous infusion fluids are pre-packaged in either glass bottles or 
plastic bags for large volume infusions (commonly intravenous fluid/electrolyte solutions) or 
plastic syringes for smaller volumes (commonly medication solutions). This study used 
infusion sets designed for both fluid bottles/bags as well as those for syringes, therefore, 
results should be seen as generalisable to both products. 
 
The ideal time frame or even the absolute longest duration of administration set usage 
remains unknown with further randomised clinical trials evaluating the impact on infection 
rates required. The results of this current study provide a sound ethical platform upon which 
future in vivo studies can occur, as these findings show that administration sets remain 
accurate and in appropriate physical condition for at least 7 days under laboratory conditions. 
Further in vitro testing would not be inappropriate as patient variables may affect 
performance. 
 
CONCLUSION 
 
Volume delivery inaccuracies detected in this study seemed to be because of the inherent 
minor fluctuations of infusion pump performance rather than the administration sets. 
Inaccuracies were constant over the week of study; that is, they did not become worse the 
longer that the set was used.  Inaccuracies found were small and clinically non-significant.  
 
Intravascular administration sets are clinically accurate and maintain appropriate physical 
condition for 7 days of continuous usage in the laboratory setting. Future research could 
include replication of this study with a larger sample, different brands of intravenous fluid 
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pump or intravenous fluids, for example lipids, or additional pump speeds. Continued in vivo 
experimentation of the relationship between prolonged administration set use and catheter 
infection rates is also required. 
 
(Word count = 3344 ) 
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TABLES 
 
Table 1 Volume, tolerance and accuracy of measuring cylinders 
Administration Set 
Rate (mL/h) 
Cylinder Volume 
(mL) 
Cylinder Tolerance 
(mL) 
Reading Accuracy 
(mL) 
2 10 +/- 0.075 +/- 0.01 
20 100 +/- 0.75 +/- 0.1 
50 250 +/- 2 +/- 0.2 
100 500 +/- 3.75 +/- 0.5 
 
Table 2 Descriptive Statistics 
Administration Set 
Rate (mL/h) 
N Min Max Mean SD SE 
2 8 7.80 7.95 7.84 .05 .01 
20 8 80.0 82.0 80.66 .57 .20 
50 7 204.0 207.0 205.35 .93 .35 
100 8 401.0 409.0 406.37 2.38 .84 
 
Table 3 Administration Set Rate 
Administration Set 
Rate (mL/h) 
t df Sig Mean difference 
2 -9.025 7 .000 -.1600 
20 3.268 7 .014 .6688 
50 15.178 6 .000 5.3571 
100 7.555 7 .000 6.3750 
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Figure 2 Mean standardised delivered volumes by programmed administration set rate 
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Figure 1 Standardised four hour delivered volumes by day of measurement 
